Skip to main content
Equibles

STATE STREET CORP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 93751 BOSTON, MA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$112,515,809
+$21,114,179 QoQ
Shares Held
6,124,976
+31.1% QoQ
Ownership
5.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 215 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. VRDN ranks #75 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in VRDN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,515,809 6,124,976
2026-03-31 $91,401,630 4,672,885
2025-12-31 $107,879,347 3,466,560
2025-09-30 $55,118,902 2,554,166
2025-06-30 $35,696,895 2,553,426
2025-03-31 $38,626,940 2,865,500
2024-12-31 $67,527,590 3,522,566
2024-09-30 $54,139,858 2,379,774
2024-06-30 $36,068,650 2,772,379
2024-03-31 $78,595,648 4,488,615
2023-12-31 $58,988,581 2,708,383
2023-09-30 $45,125,524 2,941,690
2023-06-30 $69,427,998 2,918,369
2023-03-31 $61,102,097 2,401,812
2022-12-31 $54,423,779 1,863,190
2022-09-30 $24,172,039 1,178,549
2022-06-30 $5,265,102 455,065
2022-03-31 $1,220,340 66,000
2021-12-31 $672,990 34,041
2021-09-30 $392,184 23,841
2021-06-30 $201,939 11,041